Depression, anxiety, posttraumatic stress disorder (PTSD), and substance abuse are linked to higher rates of morbidity and mortality after various surgical procedures. Comparable data in general surgery are lacking. Records from 183 consecutive patients undergoing elective general surgery procedures at a single tertiary hospital were reviewed. Patients with depression, anxiety, PTSD, and substance abuse or any combination of these at the time of surgery were classified as having “active mental illness” (AMI). Thirty-day complications, readmissions, and emergency room (ER) visits were identified. Univariate analysis was performed followed by creation of multivariate regression models. 41.5 per cent (n = 76) met criteria for the AMI group and 58.5 per cent (n = 107) were without a mental illness (WAMI). The two groups had similar incidence of medical comorbidities and similar mean values of serum albumin and creatinine. The AMI group had higher rates of readmissions (14.5 vs 3.7 %, P = 0.009) and ER (19.7 vs 8.4 %, P = 0.025) visits compared with the WAMI group. Differences in length of stay and 30-day complications did not reach statistical significance. In patients undergoing elective general surgery, depression, anxiety, PTSD, and substance abuse are associated with higher rates of readmission and ER visits. These results suggest a need for further research on the impact of specific mental illnesses on postoperative complications.

Despite the growing numbers of individuals who identify as transgender, this population continues to face worse mental health outcomes compared with the general population. Transgender individuals attempt suicide at a rate that is almost 9 times that of the general population. Few studies have reported on the positive effect of gender-affirming hormone therapy on mental health outcomes in transgender individuals. It is likely that this effect is due in part to the physiological responses that occur as a result of hormone therapy that mitigate incongruencies between one’s gender identity and assigned sex. To our knowledge, only limited studies have shown a connection between gender-affirming hormone therapy, its effect on the brain’s structure, and long-term effects that this may have on mental health outcomes. The authors propose that, in addition to the physiological responses that occur as a direct result of hormone therapy and the validation that results from receiving gender-affirming medical care, mental health outcomes in transgender individuals may also improve due to the role that hormone therapy plays in altering the brain’s structure, possibly shaping the brain to become more like that of the gender with which an individual identifies. In this article, the authors review the current literature on the effects that gender-affirming hormone therapy has on mental health outcomes and anatomic structures of the brain in transgender individuals.